Legal & General Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839K | Sell |
59,983
-232
| -0.4% | -$3.24K | ﹤0.01% | 2289 |
|
|
2025
Q1 | $812K | Buy |
60,215
+13
| +0% | +$175 | ﹤0.01% | 2251 |
|
|
2024
Q4 | $1.15M | Buy |
60,202
+11,133
| +23% | +$213K | ﹤0.01% | 2190 |
|
|
2024
Q3 | $1.12M | Buy |
49,069
+7,536
| +18% | +$171K | ﹤0.01% | 2196 |
|
|
2024
Q2 | $540K | Buy |
41,533
+2,446
| +6% | +$31.8K | ﹤0.01% | 2398 |
|
|
2024
Q1 | $684K | Buy |
39,087
+4,521
| +13% | +$79.2K | ﹤0.01% | 2317 |
|
|
2023
Q4 | $753K | Buy |
34,566
+7,206
| +26% | +$157K | ﹤0.01% | 2307 |
|
|
2023
Q3 | $420K | Sell |
27,360
-330
| -1% | -$5.06K | ﹤0.01% | 2499 |
|
|
2023
Q2 | $659K | Buy |
27,690
+11,727
| +73% | +$279K | ﹤0.01% | 2364 |
|
|
2023
Q1 | $406K | Buy |
15,963
+3,810
| +31% | +$96.9K | ﹤0.01% | 2378 |
|
|
2022
Q4 | $355K | Buy |
12,153
+1,950
| +19% | +$57K | ﹤0.01% | 2419 |
|
|
2022
Q3 | $209K | Buy |
10,203
+2,099
| +26% | +$43K | ﹤0.01% | 2613 |
|
|
2022
Q2 | $94K | Buy |
+8,104
| New | +$94K | ﹤0.01% | 2874 |
|
|
2019
Q3 | – | Sell |
-255
| Closed | -$8K | – | 3411 |
|
|
2019
Q2 | $8K | Hold |
255
| – | – | ﹤0.01% | 3398 |
|
|
2019
Q1 | $11K | Hold |
255
| – | – | ﹤0.01% | 3239 |
|
|
2018
Q4 | $12K | Hold |
255
| – | – | ﹤0.01% | 3236 |
|
|
2018
Q3 | $21K | Hold |
255
| – | – | ﹤0.01% | 3187 |
|
|
2018
Q2 | $25K | Buy |
255
+46
| +22% | +$4.51K | ﹤0.01% | 3099 |
|
|
2018
Q1 | $22K | Buy |
209
+87
| +71% | +$9.16K | ﹤0.01% | 3087 |
|
|
2017
Q4 | $19K | Hold |
122
| – | – | ﹤0.01% | 3153 |
|
|
2017
Q3 | $17K | Hold |
122
| – | – | ﹤0.01% | 3208 |
|
|
2017
Q2 | $24K | Buy |
+122
| New | +$24K | ﹤0.01% | 3119 |
|